Clinical Nutrition for Cancer Care Market
Clinical Nutrition for Cancer Care Market Trend, Opportunity, and Forecast Analysis, 2024-2032
Clinical Nutrition for Cancer Care Market is segmented by Product, Stage, Sales Channel, and by Region. KDMI analyst foresees market revenue to cross USD 8.4 Billion by 2032 by growing with a CAGR of 5.6% during 2024-2032.
Clinical Nutrition for Cancer Care Market Highlights
The global clinical nutrition for cancer care market is expected to cross a value of USD 8.4 billion by the end of 2032. The market was valued at USD 5.3 billion in 2023 and is expected to expand at a CAGR of 5.6% between 2024-2032.
- Over the mid-term, the rising prevalence of cancer is the primary factor anticipated to drive the global clinical nutrition for cancer care market.
- The lack of access to nutritional services is a major factor to challenge the market growth.
- The North America clinical nutrition for cancer care market is projected to dominate the global market.
Clinical Nutrition for Cancer Care Market: Report Scope |
|
|
Base Year |
2023 |
|
Base Year Market Size |
USD 5.3 Billion |
|
Forecast Year |
2024-2032 |
|
Forecast Year Market Size |
USD 8.4 Billion |
|
CAGR Value |
5.6% |
|
Clinical Nutrition for Cancer Care Market Key Trends/Major Growth Drivers |
|
|
Restraint Factors |
|
|
Clinical Nutrition for Cancer Care Market Segmentation |
|
|
Clinical Nutrition for Cancer Care Market Key Players |
Abbott Nutrition, Pfizer Inc., Bayer AG, Nestle Health Science S.A., GlaxoSmithKline plc, Baxter International Inc., Otsuka Holdings Co., Ltd., Mead Johnson & Company, LLC, Danone Nutricia, Victus, Inc., and others. |
Clinical Nutrition for Cancer Care Market Outlook
Clinical nutrition for cancer care involves the specialized nutritional support and interventions provided to individuals diagnosed with cancer before, during, and after cancer treatment. Clinical nutrition aims to address the challenges associated to weight loss, malnutrition, dehydration, and other nutritional deficiencies.
Our analysts at KD Market Insights predict that the rising prevalence of cancer is one of the primary factors anticipated to drive the growth of the market during the forecast period. The World Health Organization (WHO) reported that in the year 2020, nearly 10 million deaths were registered as a result of cancer, a disease which is a leading cause of death globally. As the number of cancer cases continues to increase, particularly in aging populations, the demand for specialized clinical nutrition products and services for cancer care is expected to grow, and in turn, contribute to the market growth. Abbott Nutrition, Pfizer Inc., and Bayer AG are some of the significant parties in the global market for clinical nutrition for cancer care.
Get More Insights on This Report - Request Free Sample PDF
Clinical Nutrition for Cancer Care Market Drivers – Analyst’s Observation
According to the analysts at KD Market Insights, some key growth drivers for the global clinical nutrition for cancer care market are:
- Increasing Focus on Personalized Nutrition: Personalized nutrition in cancer care is of utmost importance nowadays. This is majorly because every patient’s cancer type, treatment regimen, nutritional status, and metabolic profile are different. Our researchers have analyzed that around 40% of people undergo an unplanned weight loss when they are diagnosed with cancer. On the other hand, 40% to 80% of people who are diagnosed with the disease are known to have malnutrition. With the growing recognition regarding the importance of personalized nutrition, the need for vitamins and dietary supplements is expected to grow, in turn, contributing to the market growth.
- Rising Awareness of Benefits Associated with Nutritional Support: Healthcare providers and patients are increasingly aware of the significant role that proper nutrition plays in supporting cancer treatment outcomes, improving quality of life, and reducing treatment-related complications. As clinical nutrition plays a crucial role in survivorship care by addressing nutritional deficiencies, promoting recovery, and supporting long-term wellness, this heightened awareness among the healthcare providers and patients is driving greater acceptance and integration of clinical nutrition interventions. Such a factor is expected to contribute to the growth of the market in the coming years.
Which Probable Factors Could Hamper the Growing Clinical Nutrition for Cancer Care Market Trend?
As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of clinical nutrition for cancer care are:
- Concern for Side-Effects Related to Cancer Treatment: It has been observed most often that cancer treatments, such as chemotherapy, radiation therapy, and surgery results in treatment-related side effects. Owing to these side effects, patients undergo certain conditions where they cannot tolerate certain foods, creating challenges to maintain adequate nutrition.
- Lack of Access to Nutritional Services: Certain healthcare settings and geographic regions do not have access to specialized clinical nutrition services. This is also because of the unavailability of registered dietitians, nutrition counselors, and nutritional supplements. Also, lack of awareness regarding clinical nutrition for cancer care amongst patients from undeserved communities or rural areas is also expected to hinder the market growth in the coming years.
How is the Global Clinical Nutrition for Cancer Care Market Segmented?
Our experts at KD Market Insights have segmented the global clinical nutrition for cancer care market as:
|
By Product |
|
|
By Stage |
|
|
By Sales Channel |
|
|
By Region |
|
What are the Probable Factors Influencing the North America Clinical Nutrition for Cancer Care Market Forecast?
The North America clinical nutrition for cancer care market is majorly driven by the increasing prevalence of cancer, which according to the International Agency or Research on Cancer, registered 2380189 new cases of cancer in the United States. In addition to this, the increasing advancements in cancer treatment modalities that drives the need for specialized clinical nutrition interventions, and the rapid shift towards home healthcare are also expected to contribute to the growth of the market in the coming years.
As per our analysts at KD Market Insights, the following five players lead the North America clinical nutrition for cancer care market growth:
- Abbott Laboratories
- Nestlé Health Science
- Fresenius Kabi AG
- Danone North America
- B. Braun Medical Inc.
|
Key Countries to Watch for in North America Clinical Nutrition for Cancer Care Market |
Key Insights |
|
United States Clinical Nutrition for Cancer Care Market to Register the Largest Regional Market Share |
USD 2.4 Billion |
|
Canada Clinical Nutrition for Cancer Care Market to Grow with the Highest CAGR During 2024-2032 |
5.5% |
Which Key Players Top the Global Clinical Nutrition for Cancer Care Market Share?
As per our analysts at KD Market Insights, the competitive landscape of global clinical nutrition for cancer care market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with clinical nutrition for cancer care market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global clinical nutrition for cancer care market share:
- Abbott Nutrition
- Pfizer Inc.
- Bayer AG
- Nestle Health Science S.A.
- GlaxoSmithKline plc
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Mead Johnson & Company, LLC
- Danone Nutricia
- Victus, Inc.
What are the Recent Developments Observed in the Clinical Nutrition for Cancer Care Market?
Over the years, the experts at KD Market Insights have been observing the recent developments associated with global clinical nutrition for cancer care market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.
For instance, Kate Farms stated that it has inaugurated two new products, namely, Kate Farms Standard 1.4 Vanilla and Plain, and Kate Farms Pediatric Peptide Vanilla Flavor 1.0. These two products are indicated to treat individuals suffering from chronic diseases.
Further, Baxter International Inc. shared that it has received FDA approval for its two new formulations, namely, Clinimix and Clinimix E injections, aimed at reaching patient protein targets more effectively.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
- Publication date: 16th March 2024
- Base year: 2022
- Forecast year: 2023-2033
- Format: PDF, PPT,Word,Excel
- Quick Contact -
- ISO Certified Logo -
Frequently Asked Questions(FAQ)
Clinical Nutrition for Cancer Care Market
-: Our Clients :-
